Edition:
India

Mitsubishi Tanabe Pharma Corp (4508.T)

4508.T on Tokyo Stock Exchange

1,871JPY
11:30am IST
Change (% chg)

¥-33 (-1.73%)
Prev Close
¥1,904
Open
¥1,881
Day's High
¥1,886
Day's Low
¥1,867
Volume
1,582,500
Avg. Vol
1,329,072
52-wk High
¥2,748
52-wk Low
¥1,867

Chart for

About

Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Medical Supplies segment is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The... (more)

Overall

Beta: 0.26
Market Cap(Mil.): ¥1,459,125.00
Shares Outstanding(Mil.): 561.42
Dividend: 28.00
Yield (%): 2.00

Financials

  4508.T Industry Sector
P/E (TTM): 21.98 30.95 32.75
EPS (TTM): 118.26 -- --
ROI: 7.37 14.84 14.38
ROE: 7.89 16.34 16.07

BRIEF-Dyadic International Announces R&D Collaboration With Mitsubishi Tanabe Pharma Corp

* ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH MITSUBISHI TANABE PHARMA CORPORATION TO PRODUCE TWO TARGET PROTEINS IN C1

27 Feb 2018

BRIEF-Mitsubishi Tanabe Pharma updates license agreement with Kolon Life Secience on Invossa

* Says it notified Kolon Life Secience, Inc. (KLS) that the co seeks to cancel the license agreement between the co and KLS for Invossa, a cell therapy product for improvement of knee osteoarthritis symptoms

20 Dec 2017

Earnings vs. Estimates